Live Breaking News & Updates on Drug avastin

Stay informed with the latest breaking news from Drug avastin on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drug avastin and stay connected to the pulse of your community

Biocon Share Price: Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application

Explore Now
NEW DELHI: Shares of Biocon fell nearly 4 per cent in Monday's trade after the biotechnology major said that the US health regulator has deferred action on the biologics license application (BLA) for a biosimilar to drug Avastin, used to treat various types of cancers.
Following the development, the stock fell 3.89 per cent to hit a low of Rs 463.05 on BSE.
Biocon's arm Biocon Biologics and Mylan, a subsidiary of Viatris Inc, have been informed by the US Food and Drug Administration (USFDA) of a deferred action on the BLA for MYL-1402O, a proposed biosimilar to Avastin (bevacizumab), Biocon said in a regulatory filing.

Biocon-biologics , Biocon , Drug-administration , Viatris-inc , Biocon-share-price , Biocon-ltd , Drug-avastin , Usfda , During-market , Us-health-regulator , The-us-food-and-drug-administration , பயோகான்-உயிரியல்

Detailed text transcripts for TV channel - FOXNEWS - 20120215:16:44:00

ones side by side. i don't distinguish too much of a difference, right? the maker of the drug is warning doctors and patients that the fake products does not contain the key greedens used to treat various cancers. joining us live, marc siegl, professor of medicine at nya's langone medical center. how does this even happen? >> this is a scary situation because first of all, the drug avastin is a revolutionary drug. it's expensive. it costs about 90-$100,000 a year. but it literally blocks cancer from increasing their blood supply to the tumor. by blocking the protein that causes this. so it's a very important drug. and this happens because fake suppliers are in there, one called quality specialty products, another, montana health care solutions. they get in the way of the normal distributor that goes right to the drug company and gives me the drug and sells it to the hospital or the practice. practices out there that are

Drug , Warning , Difference , Patients , Doctors , Products , Maker , Ones , Greedens , Side-by , All , Marc-siegl

Detailed text transcripts for TV channel - CNN - 20100917:15:29:00

>> before push cart, they saw it as a symbol of poverty. now it is a symbol of hope. >> his story has been told in six countries and can be seen on philippine television. a young man from the slums has turned the attention of the nation toward a common dream. >> my fellow countrymen are unleashing the hero inside them. thank you. >> who will be the cnn hero of the year for 2010? you decide. we will decide next thursday and will announce it on cnn.com on 1:00 p.m. when you can vote on line for the cnn hero who inspires you the most. thousands of american women with breast cancer use the drug avastin. what happens if it loses its fda approval. the decision is expected today and we'll hear how it could impact women all across the country. ♪ you're the one

Poverty , Story , Hope , Symbol , Countries , Push-cart-classroom , Philippine-television , Six , Man , Attention , Hero , Nation